Your browser doesn't support javascript.
loading
High incidence of cetuximab-related infusion reactions in head and neck patients.
Palomar Coloma, Virginia; Bravo, Pamela; Lezghed, Naima; Mayache-Badis, Lamia; Herrera Gómez, Ruth Gabriela; Iacob, Mariana; Nicouleau, Laurence; Desmaris, Romain; Tao, Yungan; Leibu, Cristian; Matias, Margarida; Lemare, Francois; Even, Caroline; Annereau, Maxime; Ferté, Charles.
Afiliação
  • Palomar Coloma V; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France. Electronic address: virpalomarcoloma@gmail.com.
  • Bravo P; Department of Pharmacy, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
  • Lezghed N; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France.
  • Mayache-Badis L; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France.
  • Herrera Gómez RG; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France.
  • Iacob M; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France.
  • Nicouleau L; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France.
  • Desmaris R; Department of Pharmacy, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
  • Tao Y; Department of Radiation Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
  • Leibu C; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France.
  • Matias M; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France.
  • Lemare F; Department of Pharmacy, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France; Laboratory of Clinical pharmacy, Faculté de pharmacie Paris Descartes, Université Sorbonne-Paris-Cité, Paris, France.
  • Even C; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France.
  • Annereau M; Department of Pharmacy, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
  • Ferté C; Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Villejuif, France; INSERM U1030, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, Select, France; Drug Development Department (DITEP), Gustave Roussy, Uni
ESMO Open ; 3(5): e000346, 2018.
Article em En | MEDLINE | ID: mdl-30094066
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: ESMO Open Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: ESMO Open Ano de publicação: 2018 Tipo de documento: Article